Abstract Aim: Despite the growing importance of public and patient involvement in biomedical research, comparatively little attention has been paid to the important role of research participants themselves. Our aim in this paper is to explore the impact research participant involvement has within the PREVENT and the European Prevention of Alzheimer's Dementia (EPAD) projects. Method: In this paper, we report the experiences of involving research participants as collaborators in prospective cohort studies exploring early changes in the brain as pathways towards and risks for dementia. We use minutes and feedback from members of the panel and steering committee to understand the experience and impact on the study. Results: We describe the aims and structure of the participant panel established within the PREVENT Dementia study and highlight its contributions to the organisation, conduct and future of the study. Key areas of contribution identified include recruitment, inclusion of additional substudies, understanding the participant experience and contributing to the future of the study. Discussion: We then describe how the PREVENT Dementia panel forms the basis for participant involvement within EPAD project.
Introduction
The PREVENT Dementia study (Ritchie & Ritchie, 2012 ) is a prospective cohort study which aims to identify risk factors for dementia in mid-life, recruiting participants with and without a family history of dementia aged 40-59. It is now widely agreed that the changes in the brain that lead to dementia have their genesis in mid-life (Ritchie et al., 2015) and the measurement of these changes over time and association with fixed and modifiable risks is crucial in order to develop accurate disease models. Participation in PREVENT Dementia involves a long-term commitment from 700 participants who complete multiple assessments over the course of a full day, with separate scheduled visits for MRI and optional lumbar punctures. All assessments are repeated at follow up visits two years after baseline. Participants are provided with refreshment and travel expenses of up to £20 each year.
In addition to conventional mechanisms for patient and public involvement (PPI), which often focus on the framing and setup of research projects, PREVENT Dementia has established a participant panel which aims to learn from research participants and provide them an active voice in the project. Participant involvement acknowledges that people who participate in research can contribute relevant knowledge and experience to ongoing and future research activities. There is growing interest in involving participants as active partners in research, including in the US 'All of Us' precision medicine initiative and UK 100,000 Genomes project (Genomics England, n.d.; PMI Working Group, 2015) . However, efforts in this area have often been sporadic, and few models to enable an ongoing conversation between researchers and participants have been described, particularly in large scale studies (Sankar & Parker, 2017; Vale et al., 2018) .
There are two main arguments for such expanded public, patient and participant involvement 'PPPI' in health research: moral and methodological. Moral arguments suggest that involvement is a right, citizens should have a voice in publicly funded research and individuals have the right to be involved in planning and assessing any research intervention potentially done 'to' them (Dresser, 2016) . PPPI activities thus establish a reciprocal relationship between researchers and participants that recognises the latter's contribution and interest in the study. They may also establish accountability and transparency between the study goals and the study population, and provide an opportunity for researchers to respond to participants' concerns. Furthermore, methodologically, participant involvement can provide insights into the research process, leading to more user-friendly and userfocused research objectives, questions and study information, improved consent procedures, assessments and enhanced implementation and dissemination of study results (Brett et al., 2014; Morris & Balmer, 2006) .
The PREVENT Dementia participant panel comprises of seven participants and one non-participant who meet on a quarterly basis with the project's Chief Investigator and National Coordinator to discuss progress on the project, future aims and review potential sub-studies or proposed analyses. Expressions of interest to join the panel were initially sent out prior to study initiation via memory clinics to people aged 40-59 caring for someone with dementia. Additional invites to join have been extended to recruited participants to ensure the panel retains a minimum of seven members. The National Coordinator arranges the meetings and a standing agenda is used with all panel members encouraged to contribute. The meeting is chaired either by the Chief Investigator or National Coordinator. Two members of the participant panel take part in bi-annual steering committee meetings, joining researchers to maintain an overview of the study progress and deal with study related issues and future developments. The steering committee was established to oversee the successful running of the study and is attended by site leads and experts within the field. Panel members also attend an annual conference and other public engagement events, contributing to interviews on radio, and national and local news, to help disseminate study results in a lay friendly manner.
Methods
In this paper, we analyse the minutes of participant panel and steering committee meetings between 2013 and 2017, the perspective and experience of panel members themselves, and researcher and steering committee member reflections on the value and role of the PREVENT Dementia participant panel. Outcomes are reported in line with GRIPP2-LF criteria (Staniszewska et al., 2017) .
First, we examined the minutes from 15 participant panel meetings that have taken place to date, covering meetings dating prior to study initiation, through to present day where the study is open at five sites across the UK and Ireland. We identified areas in which we felt the participant panel had impacted on the study.
Second, we provided a brief summary of the aim of this paper to the participant panel and steering committee and garnered feedback from both groups about their perceptions of the role and impact of the panel, as well as any challenges that may have arisen through this, with contributions from two members of each group. Common themes in this feedback were then identified.
Results
Participant panel and steering committee meeting minutes suggest four areas in which PPPI has had an important influence in PREVENT Dementia. These include (1) recruitment, (2) assessment of the burden and value of sub-studies, (3) study procedures and the experience of participation and (4) contributing to the future maintenance of the study. Panelists and steering committee members also provided reflections of the value of the panel contribution, the experience of taking part in the panel, and potential limitations of the participant panel model.
Recruitment
The panel has frequently discussed suggestions for recruitment strategies and were proponents of the study to friends and family, proving one of the most successful mechanisms to identify new volunteers.
The panel felt that they supported recruitment through being 'so committed' to the project and being 'able to support all the new recruitment with our feedback and press and being part of JDR [Join Dementia Research]'. PREVENT Dementia was a key study involved in the original development of the JDR website. Participants spoke of themselves as 'ambassadors' for the study. For some, this has extended to an advocacy role on behalf of the study and to help '[wear] away. . .some of the fear and stigma' associated with dementia.
The steering committee commented that the participant panel had been able to guide and advise on appropriate recruitment strategies that the study should take. The panel helped the steering committee to predict some of the reasons why people may not engage with the study and provided constructive feedback on the participant information sheet to help researchers ensure comprehensibility and improve the recruitment of participants without a family history of dementia, a target group more difficult to recruit.
Assessing the value and potential burden of sub-studies
The participant panel further advised on the acceptability and feasibility of follow-up studies which have involved re-contacting PREVENT Dementia participants. Since initiation many researchers have expressed interest in collaboration through the addition of small substudies recruiting participants directly from PREVENT Dementia. Prior to these studies being approved, they are discussed with the steering committee and the participant panel to examine potential benefits and risks to including the sub-study.
Examples of such studies include the exploration of linguistic ability in the PREVENT Dementia population, through the completion of an online based set of assessments. The panel agreed it would be an interesting study to include and would only be a minor time burden. A second study involved recruitment for qualitative social science research on expectations associated with learning biomarker results related to Alzheimer's disease risk . In rejecting other studies, the panel highlighted the time burden or issues that would make recruitment to the study difficult.
Steering committee members also highlighted the role of the panel in helping to determine which sub-studies participants might be interested in volunteering for. Presented with concerns about time burden or intrusiveness of additional studies, the panel would help advise whether these were acceptable for the sub-study in question.
Study experience and procedures
The panel have been involved in adapting and providing feedback on study procedures. One notable example relates to optional lumbar punctures, used to obtain spinal fluid samples, within PREVENT Dementia. The panel were instrumental in providing feedback on the information surrounding this procedure, leading to the co-development with the Alzheimer's Society of a video explaining the procedure for a lay audience. This resource is cited by local research teams as one of the reasons behind recent higher uptake rates of the procedure.
The example of the lumbar puncture was also highlighted in panelists' reflections on their contribution to the study. This had been an area of reluctance for many participants, including those on the panel. The panel felt that having an open environment in which they could have a 'discussion of what the actual issues are and effective solutions to those with a video being made to allay the fears of some'. They also noted that having the panel may have helped to remind the research team of the importance to treat each participant as an individual, rather than the 'next number on a "conveyor belt"'.
The steering committee reflected more broadly on the role of the panel in improving the study experience. They highlighted the role of the panel in revising the wording of study documents and valued the panel as a 'sounding board' for on-going study issues. Finally, they discussed the panel's importance for communicating concerns from the study to the steering committee, enabling problems to be solved and ultimately supporting study retention.
Supporting the future
Finally, the participant panel has been integral to thinking about ways of developing and supporting the study's longitudinal impact. PREVENT Dementia received grant funding from three separate sources to establish the initial cohort. It now also has a membership scheme and grassroots fundraising activity, which contributes to extending the study and undertaking sample and data analysis not covered by the original grants. The participant panel was pivotal in establishing the donations and philanthropic funding stream, from the development and promotion of the membership scheme, to contributing to conversations about how the funds raised through the membership scheme are best invested.
Commenting on this contribution, panel members felt the membership scheme and fundraising scheme was 'the obvious way to link people in', as more people wanted to be involved in the study than recruitment could support. The panel felt the membership scheme would allow the wider public to 'be involved in some way and be part of the discussion and debate and ultimately the solution [to Alzheimer's disease]'.
The experience and value of panel involvement
The participant panel demonstrated a clear feeling of having contributed significantly to PREVENT Dementia. The steering committee feedback was similarly overwhelmingly positive, reflecting on their experiences of working so directly with participants in forming and running the study. One panel member summarised how they felt the panel enables them to contribute to the project through their lived experiences:
[the panel] gives a unique effectively service user voice, as the participants are speaking on behalf of themselves and their involvement but also their experiences of those family members and loved ones which gives us insight and inspires real commitment to doing the very very best to move things forward in this area.
Ultimately the members of panel felt being part of the panel 'has given us the voice, the power and the ability to come together and bring about change'.
Members of the panel had also derived personal benefit from being involved in the panel. Some had increased their scientific understanding, which in turn helped them to support others living through the experience of caring for someone with dementia. The panel felt part of the research team and looked forward to the meetings, feeling united with the researchers through having 'a mutual goal' and being supported as 'a team' and 'a family'. The panel appreciated the time committed by the researchers and hoped that the participants enthusiasm helped to demonstrate how much the study was, and still is, valued.
Limitations of the participant panel
The steering committee members discussed the potential for a situation arising in which the panel have concerns that would be difficult to assimilate into the study protocol whilst maintaining clinical efficiency and scientific rigor. The steering committee acknowledged this would be their challenge to handle diplomatically and to discuss and debate these situations as and when they arose.
PREVENT Dementia has now opened at multiple sites across the UK and Ireland. This brings with it a challenge of how to elicit continued participant input from the newer sites. This is a key focus for the steering committee and panel to develop over the coming months.
Discussion
The contribution of the participant panel in PREVENT Dementia has been overwhelmingly positive. Feedback from panel members, steering committee, and the evidence of panel's impact suggest that it has been a positive, rewarding experience that has successfully contributed towards the design and running of the study.
Support for recruitment was highlighted as one of the major contributions the panel has had on the study. Given that recruitment is often the largest hurdle a study has to overcome, particularly in dementia research (Bartlett, Milne, & Croucher, 2018; Iliffe, Mcgrath, & Mitchell, 2013; Larsen et al., 2015) , having dedicated advocates of the study from the population which the study is attempting to reach is undoubtedly an advantage. Due to panel input information presented about the study has been accessible and user friendly, and recruitment avenues have been used that may not otherwise have been identified. The panel has also been able to support with the addition of sub studies. While the steering committee have a role in determining the scientific value of the additional research questions, they have consulted the participant panel to determine whether the additional burden would be acceptable. Although the study only asks participants to return after two years, the study visit day is relatively intense, and as such it has been important to balance the drive for data with the need to retain participants by not over-burdening them. This has been an important area to discuss as there is evidence that in longitudinal studies with older people participants were more likely to refuse to complete follow up visits if they were contacted to participate in one to four sub-studies (Bhamra, Tinker, Mein, Ashcroft, & Askham, 2008) .
The steering committee reflected upon possible challenges that can arise through collaborating with participants on a study, including the different perspectives and priorities with which each member may approach the research question. These are challenges for researchers to consider and tackle in an appropriate way. Finally, it is essential to avoid the collaboration with research participants being a tokenistic endeavour by ensuring that there are clear aims and objectives for participant involvement, and that feedback on the scope and value of involvement is sought and acted upon.
Future development

Development of the PREVENT Dementia participant panel
Membership of the panel has remained fairly static, and it has been more difficult to involve more recent participants. The PREVENT Dementia team are currently developing mechanisms to ensure this can happen, with plans to garner feedback from participants in all centres, feeding into a central panel.
Development of the EPAD participant panels
PREVENT Dementia has clearly benefited from active and continuing participant involvement and offers a template for replication in other studies contemplating on-going participant involvement (see Box 1). Such mechanisms for involvement require careful consideration as to the method, scope and aims, as well as reflection on how participant involvement will be acted upon.
One study drawing on the PREVENT Dementia PPPI model is the European Prevention of Alzheimer's Dementia (EPAD) study. EPAD is a major cross-European project which involves a longitudinal cohort study and linked adaptive clinical trials platform (Ritchie et al., 2015) . The EPAD study has two aims: to facilitate recruitment into adaptive clinical trials which aim to delay or prevent the onset of Alzheimer's dementia, and to enable disease modelling to identify the earliest pathological changes of Alzheimer's disease.
The EPAD population is similar to that recruited in the PREVENT Dementia study, albeit with greater diversity of recruitment sources, and a pan-European focus. In EPAD, participant involvement has been planned from the outset, informed by the PREVENT Dementia model. Local EPAD participant panels are currently active at three centres, contributing to a central study panel. Learning from the PREVENT Dementia project has been facilitated by the overlap and close relationships between academics in the two projects and the fact that EPAD participants are contacted through, and often co-enrolled in, other cohorts, including PREVENT Dementia (Vermunt et al., 2018) The organisation of the EPAD panels has been informed by the PREVENT Dementia experience. The PREVENT Dementia panel highlighted that local research team Establish PPI involvement prior to study initiation. Develop an agenda for meetings to cover areas that PPPI input can benefit. Plan for the expansion of PPPI input to ensure it remains valid and avoids being tokenistic by implementing terms of reference. Involve local research staff with PPPI groups to keep momentum and ensure feedback can be actioned.
engagement is crucial to build the panel, establish expectations for panel input and continue momentum. Similarly, EPAD staff provide administrative support and attend meetings where requested to give feedback on the study progress and to ensure participant comments and suggestions are fed back via the correct avenues. However, an important feature of this process is allowing participants to set the agenda. All EPAD participants are approached after their six-month visit to ascertain their interest in joining the panel. Once the panel has reached capacity (10 participants), a waiting list is started. EPAD panels have nominated participant chairs who serve for two years.
As a multi-centre pan-European study, EPAD has established terms of reference to ensure consistency across each centre, with a central panel drawing together members from each centre. This approach aims to capture the local influence and impact of the PREVENT Dementia panel, and translate it to a larger scale, avoiding the panel becoming a forum that is not able to effect change within the study.
Conclusion
The PREVENT Dementia participant panel has been a valuable experience for both the study team and panellists. It has contributed to study recruitment and retention, study experience, the assessment of burden associated with sub-studies and to the development of strategies for the future funding and continuation of the study. As such, participants have become collaborators in the development of the project. The PREVENT Dementia experience has provided a key reference point in making the case for, and devising the format of, participant involvement within EPAD, and may offer similar potential for future studies.
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